• CANAKINUMAB chembl:CHEMBL1201834 ApprovedAntineoplasticImmunotherapy

    Alternate Names:

    ILARIS
    ACZ-885
    CANAKINUMAB
    ACZ885
    chemidplus:914613-48-2
    drugbank:06168
    chembl:CHEMBL1201834
    rxcui:853491

    Drug Info:

    FDA Approval Juvenile idiopathic arthritis
    Drug Class Therapeutic Antibodies
    FDA Approval approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,DMARD
    Drug Class anti-inflammatory agents
    Year of Approval 2009
    (2 More Sources)
    • Version: 20-Jun-2017

    Alternate Names:
    ACZ885 Development Name
    CANAKINUMAB Generic Name
    ILARIS Trade Name

    Drug Info:
    Drug Class Therapeutic Antibodies
    FDA Approval Juvenile idiopathic arthritis

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    CANAKINUMAB Primary Drug Name

    Drug Info:
    Year of Approval 2009
    Drug Class anti-inflammatory agents

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,DMARD
    Drug Class monoclonal antibody
    FDA Approval approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0TD2G TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: